Treatment of mild-to-moderate asthma in childhood and adolescence in 2021

Affiliations

¹ Department of Pediatrics, Section of Allergy and Clinical Immunology, University of Manitoba, Winnipeg R2A 5L9, MB, Canada; Department of Pediatrics, Division of Allergy and Immunology, University of British Columbia, Vancouver, BC, Canada. Electronic address: eabram10@jhu.edu.
² Dartmouth-Hitchcock Medical Center, Section of Allergy and Immunology, Lebanon, NH, USA; Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
³ Section of Allergy/Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA.
⁴ Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal; Department of Pediatrics, Santa Maria Hospital, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Center, Lisbon, Portugal.
⁵ Alder Hey Children's Hospital, Liverpool, UK; Division of Child Health, University of Liverpool, Liverpool, UK.

Elissa M Abrams et al. Lancet Respir Med. 2021 May.

. 2021 May;9(5):443-445.

doi: 10.1016/S2213-2600(21)00135-1. Epub 2021 Mar 12.

¹ Department of Pediatrics, Section of Allergy and Clinical Immunology, University of Manitoba, Winnipeg R2A 5L9, MB, Canada; Department of Pediatrics, Division of Allergy and Immunology, University of British Columbia, Vancouver, BC, Canada. Electronic address: eabram10@jhu.edu.
² Dartmouth-Hitchcock Medical Center, Section of Allergy and Immunology, Lebanon, NH, USA; Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
³ Section of Allergy/Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA.
⁴ Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal; Department of Pediatrics, Santa Maria Hospital, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Center, Lisbon, Portugal.
⁵ Alder Hey Children's Hospital, Liverpool, UK; Division of Child Health, University of Liverpool, Liverpool, UK.

No abstract available

Comment in

Has the time come to end use of the blue inhaler?
Bush A, Dalziel SR, Byrnes CA, Hatter L, Beasley R. Bush A, et al. Lancet Respir Med. 2021 Jun;9(6):e51. doi: 10.1016/S2213-2600(21)00185-5. Epub 2021 Apr 28. Lancet Respir Med. 2021. PMID: 33932346 No abstract available.